First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.
Choi E, Michalski CJ, Choo SH, Kim GN, Banasikowska E, Lee S, Wu K, An HY, Mills A, Schneider S, Bredeek UF, Coulston DR, Ding S, Finzi A, Tian M, Klein K, Arts EJ, Mann JF, Gao Y, Kang CY.
Choi E, et al. Among authors: tian m.
Retrovirology. 2016 Nov 28;13(1):82. doi: 10.1186/s12977-016-0317-2.
Retrovirology. 2016.
PMID: 27894306
Free PMC article.
Clinical Trial.